Understanding internalization of rotavirus VP6 nanotubes  by cells: towards a recombinant vaccine.
Rotavirus VP6 nanotubes are an attractive option for a recombinant vaccine against rotavirus disease. Protection against rotavirus infection and an adjuvant effect have been observed upon immunization with VP6 nanotubes. However, little information exists on how VP6 nanotubes interact with cells and trigger an immune response. In this work, the interaction between VP6 nanotubes and different cell lines was characterized. VP6 nanotubes were not cytotoxic to any of the animal or human cell lines tested. Uptake of nanotubes into cells was cell-line-dependent, as only THP1 and J774 macrophage cells internalized them. Moreover, the size and spatial arrangement of VP6 assembled into nanotubes allowed their uptake by macrophages, as double-layered rotavirus-like particles also displaying VP6 in their surface were not taken up. The internalization of VP6 nanotubes was inhibited by methyl-β-cyclodextrin, but not by genistein, indicating that nanotube entry is specific, depends on the presence of cholesterol in the plasma membrane, and does not require the activity of tyrosine kinases. The information generated here expands our understanding of the interaction of protein nanotubes with cells, which is useful for the application of VP6 nanotubes as a vaccine.
Mabel
M
Rodríguez
Christopher
C
Wood
Rosana
R
Sanchez-López
Ricardo M
RM
Castro-Acosta
Octavio T
OT
Ramírez
Laura A
LA
Palomares
D000818:Animals; D000956:Antigens, Viral / Q000276:immunology* / Q000378:metabolism*; D019556:COS Cells; D018938:Caco-2 Cells; D036022:Capsid Proteins / Q000276:immunology* / Q000378:metabolism*; D002522:Chlorocebus aethiops; D002784:Cholesterol; D004705:Endocytosis / Q000187:drug effects; D019833:Genistein / Q000494:pharmacology; D057809:HEK293 Cells; D006801:Humans; D043942:Nanotubes / Q000737:chemistry / Q000821:virology*; D011505:Protein-Tyrosine Kinases; D012401:Rotavirus / Q000276:immunology / Q000502:physiology*; D014614:Vaccines, Synthetic; D014765:Viral Vaccines / Q000276:immunology; D053586:Virus Internalization; D047392:beta-Cyclodextrins / Q000494:pharmacology
D000956:Antigens, Viral; D036022:Capsid Proteins; C061332:VP6 protein, Rotavirus; D014614:Vaccines, Synthetic; D014765:Viral Vaccines; D047392:beta-Cyclodextrins; C108732:methyl-beta-cyclodextrin; D002784:Cholesterol; D019833:Genistein; D011505:Protein-Tyrosine Kinases